The 13th Alzheimer`s and Parkinson`s Drug Development Summit is dedicated to CNS Biopharma to Revolutionize the Next Wave of Neurodegenerative Therapeutics.
Topics
Novel modelling methods to bolster recapitulation of the CNS
Fortifying the neurodegenerative field: strategic positioning of future pipelines
Biology & beyond – understanding the fundamentals to map future pathological targets in alzheimer’s
Mapping clinical study design for efficient timelines in high investment neurodegenerative trials
Restoring confidence & progressing trust for future neurodegenerative drug development
Upcoming applications in alzheimer’s disease – varying strategies to approach successful treatment
The spectrum of technologies employed to boost neuro-discovery
Tackling the multiple approaches to degenerative disease & enriching modern development tactics